Study the Effect of Water Kefir Consumption on the Gut Microbiome in Healthy Adults

Sponsor
Lund University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05657730
Collaborator
(none)
63
1
1
5.1
12.4

Study Details

Study Description

Brief Summary

The goal of this intervention study is to analyse the microbiota composition after the water kefir consumption. The main questions are to evaluate the potential probiotic drink can have beneficial effect on the gut microbiota. Participants will consume the water kefir for two weeks and microbiota will be analysed. Researchers will compare the microbiota composition before and after consumption.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Water Kefir beverage
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
63 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Analysis of the Intestinal Flora Composition After Consumption of Water Kefir
Actual Study Start Date :
Nov 10, 2022
Anticipated Primary Completion Date :
Jan 14, 2023
Anticipated Study Completion Date :
Apr 14, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active group

Dietary Supplement: Water Kefir beverage
Participants will consume the water kefir beverage for two weeks.

Outcome Measures

Primary Outcome Measures

  1. 16S metagenomics based measurement of the bacterial diversity (alpha- and beta diversity indices), and the composition (relative abundance of the bacterial taxa in each sample) [up to 24 weeks]

    Potential changes of microbiome after consumption of the water kefir will be assessed by analyzing the 16S metagenomics

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-65 years of age.

  • must be able to complete the form digitally.

Exclusion Criteria:
  • must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency such as MS, type 1 diabetes, cancer or HIV.

  • must not take antibiotics during the study period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lund University Lund Skåne Sweden 22100

Sponsors and Collaborators

  • Lund University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Åsa Håkansson, Associate Professor, Lund University
ClinicalTrials.gov Identifier:
NCT05657730
Other Study ID Numbers:
  • Water Kefir
First Posted:
Dec 20, 2022
Last Update Posted:
Dec 20, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Dec 20, 2022